NCT02267200View on ClinicalTrials.gov

The Screening and Analysis of Plasma Biomarkers in Irreversible PAH-CHD

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Hypertension,Pulmonary
Trial Locations (1)

200127

Shanghai Children's Medical Center, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT02267200 - The Screening and Analysis of Plasma Biomarkers in Irreversible PAH-CHD | Biotech Hunter | Biotech Hunter